Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Mar-23 4:16 PM View:  | Uniqure N.V. (QURE) | 27-Feb-23 | Market Sale | 384 | $19.97 | $7,668.48 | (2%) 16.38K to 16.0K | 2% |
| 20-Jan-23 3:57 PM View: | Uniqure N.V. (QURE) | 18-Jan-23 | Option Exercise | 6,000 | $5.37 | $32,220.00 | 37% 16.38K to 22.38K | |
| 20-Jan-23 3:57 PM View: | Uniqure N.V. (QURE) | 18-Jan-23 | Planned Option Sale | 6,000 | $22.59 | $135,540.00 | (27%) 22.38K to 16.38K | |
| 15-Dec-22 5:09 PM View: | Uniqure N.V. (QURE) | 14-Dec-22 | Option Exercise | 3,800 | -- | -- | 23% 16.38K to 20.18K | |
| 15-Dec-22 5:09 PM View: | Uniqure N.V. (QURE) | 14-Dec-22 | Planned Option Sale | 3,800 | $23.43 | $89,034.00 | (19%) 20.18K to 16.38K | |
| 15-Dec-22 5:09 PM View: | Uniqure N.V. (QURE) | 13-Dec-22 | Option Exercise | 3,000 | $5.37 | $16,110.00 | 18% 16.38K to 19.38K | |
| 15-Dec-22 5:09 PM View: | Uniqure N.V. (QURE) | 13-Dec-22 | Planned Option Sale | 3,000 | $23.45 | $70,350.00 | (15%) 19.38K to 16.38K | |
| 01-Dec-22 4:14 PM View: | Uniqure N.V. (QURE) | 29-Nov-22 | Option Exercise | 6,200 | -- | -- | 38% 16.38K to 22.58K | |
| 01-Dec-22 4:14 PM View: | Uniqure N.V. (QURE) | 29-Nov-22 | Planned Option Sale | 6,200 | $25.38 | $157,356.00 | (27%) 22.58K to 16.38K | |
| 17-Jun-22 4:31 PM View: | Uniqure N.V. (QURE) | 15-Jun-22 | Grant | 9,080 | -- | -- | 124% 7.3K to 16.38K | |
| 02-Mar-22 5:26 PM View: | Uniqure N.V. (QURE) | 28-Feb-22 | Market Sale | 596 | $16.87 | $10,054.50 | (8%) 7.9K to 7.3K | (16%) |
| 28-Feb-22 6:15 PM View: | Uniqure N.V. (QURE) | 24-Feb-22 | Grant | 1,534 | -- | -- | 24% 6.36K to 7.9K | |
| 04-Mar-21 2:19 PM View: | Uniqure N.V. (QURE) | 02-Mar-21 | Market Sale | 504 | $37.60 | $18,950.40 | (7%) 6.87K to 6.36K | 8% |
| 01-Mar-21 4:23 PM View: | Uniqure N.V. (QURE) | 25-Feb-21 | Grant | 2,382 | -- | -- | 53% 4.49K to 6.87K | |
| 02-Mar-20 3:49 PM View: | Uniqure N.V. (QURE) | 27-Feb-20 | Grant | 2,063 | -- | -- | 85% 2.42K to 4.49K | |
| 05-Feb-20 1:19 PM View: | Uniqure N.V. (QURE) | 05-Feb-20 | Market Sale (Planned) | 2,122 | $60.95 | $129,332.00 | (47%) 4.54K to 2.42K | 37% |
| 30-Jan-20 9:15 PM View: | Uniqure N.V. (QURE) | 28-Jan-20 | Market Sale | 807 | $62.19 | $50,187.30 | (15%) 5.35K to 4.54K | 39% |
| 08-Jan-20 1:48 PM View: | Uniqure N.V. (QURE) | 07-Jan-20 | Market Sale (Planned) | 3,000 | $72.18 | $216,540.00 | (36%) 8.35K to 5.35K | 47% |
| 17-Dec-19 4:06 PM View: | Uniqure N.V. (QURE) | 13-Dec-19 | Option Exercise | 2,000 | $5.37 | $10,740.00 | 24% 8.35K to 10.35K | |
| 17-Dec-19 4:06 PM View: | Uniqure N.V. (QURE) | 13-Dec-19 | Market Option Sale (Planned) | 2,000 | $70.50 | $141,000.00 | (19%) 10.35K to 8.35K | 46% |
| 09-Dec-19 6:30 PM View: | Uniqure N.V. (QURE) | 09-Dec-19 | Market Sale (Planned) | 2,500 | $67.50 | $168,750.00 | (23%) 10.85K to 8.35K | 44% |
| 09-Dec-19 6:30 PM View: | Uniqure N.V. (QURE) | 06-Dec-19 | Market Sale (Planned) | 9,082 | $64.26 | $583,600.00 | (46%) 19.93K to 10.85K | 41% |
| 30-Sep-19 5:52 PM View: | Akcea Therapeutics, Inc. (AKCA) | 26-Sep-19 | Payment of Exercise | 1,383,710 | $16.64 | $23,025,000.00 | (67%) 2.06M to 678.15K | |
| 30-Sep-19 5:52 PM View: | Akcea Therapeutics, Inc. (AKCA) | 26-Sep-19 | Option Exercise | 2,061,860 | $7.05 | $14,538,300.00 | 100% 0 to 2.06M | |
| 09-Apr-19 6:59 PM View: | Akcea Therapeutics, Inc. (AKCA) | 08-Apr-19 | Option Exercise | 1,787 | $6.48 | $11,579.80 | 100% 0 to 1.79K | |
| 09-Apr-19 6:59 PM View: | Akcea Therapeutics, Inc. (AKCA) | 08-Apr-19 | Market Option Sale (Planned) | 1,787 | $32.17 | $57,480.30 | (100%) 1.79K to 0 | |
| 09-Apr-19 6:59 PM View: | Akcea Therapeutics, Inc. (AKCA) | 05-Apr-19 | Option Exercise | 30,000 | $6.48 | $194,400.00 | 100% 0 to 30.0K | |
| 09-Apr-19 6:59 PM View: | Akcea Therapeutics, Inc. (AKCA) | 05-Apr-19 | Market Option Sale (Planned) | 30,000 | $32.11 | $963,300.00 | (100%) 30.0K to 0 | |
| 07-Mar-19 5:20 PM View: | Akcea Therapeutics, Inc. (AKCA) | 06-Mar-19 | Option Exercise | 18,386 | $6.48 | $119,141.00 | 100% 0 to 18.39K | |
| 07-Mar-19 5:20 PM View: | Akcea Therapeutics, Inc. (AKCA) | 06-Mar-19 | Market Option Sale (Planned) | 18,386 | $32.14 | $590,856.00 | (100%) 18.39K to 0 | |
| 30-Jan-19 5:28 PM View: | Uniqure N.V. (QURE) | 28-Jan-19 | Market Sale | 1,210 | $31.32 | $37,897.20 | (6%) 21.14K to 19.93K | (22%) |
| 29-Jan-19 8:37 PM View: | Uniqure N.V. (QURE) | 25-Jan-19 | Grant | 3,230 | -- | -- | 18% 17.91K to 21.14K | |
| 31-Jan-18 10:51 AM View: | Uniqure N.V. (QURE) | 29-Jan-18 | Market Sale | 2,878 | $18.53 | $53,329.30 | (14%) 20.79K to 17.91K | (106%) |
| 30-Jan-18 10:46 AM View: | Uniqure N.V. (QURE) | 26-Jan-18 | Grant | 4,792 | -- | -- | 30% 16.0K to 20.79K |